In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 25 | Yes |
Popular Name: VORICONAZOLE VORICONAZOLE
Find On: PubMed — Wikipedia — Google
CAS Numbers: , 136285-65-9 , 137234-62-9 , 137234-63-0 , 137330-52-0 , 182230-43-9 , [137234-62-9]
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
137234-62-9; C07622; Vfend; Voriconazole
137234-62-9; D00578; Vfend (TN); Voriconazole (JAN/USAN/INN)
2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
CPD000466350; SAM001246664; VORICONAZOLE
voriconazol; voriconazole; voriconazolum
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.49 | 8.74 | -8.45 | 1 | 6 | 0 | 77 | 349.316 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
purity | 9.500000000000000e+001 | Enamine Building Blocks |
ALOGPS_SOLUBILITY | 9.78e-02 g/l | DrugBank-approved |
purity | 95 | Enamine Building Blocks |
Purity | 98% | Fluorochem |
Purity | 99% | Fluorochem |
Therapy | antifungal | SMDC Pharmakon |
UniProt Database Links | CHK1_CANAL; SSK1_CANAL | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sequoia Research Products Ltd.; NCC_SUPPLIER_STRUCTURE_ID : SRP01070v | NIH Clinical Collection via PubChem |
Target | P450 | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sequoia Research Products Ltd.; SUPPLIER_STRUCTURE_ID: SRP01070v | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CP2B6-2-E | Cytochrome P450 2B6 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 790 | 0.34 | ADME/T ≤ 10μM |
CP2C9-1-E | Cytochrome P450 2C9 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8400 | 0.28 | ADME/T ≤ 10μM |
CP2CJ-1-E | Cytochrome P450 2C19 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 8700 | 0.28 | ADME/T ≤ 10μM |
Q96W81-1-F | 14-alpha Sterol Demethylase (cluster #1 Of 1), Fungal | Fungi | 429 | 0.36 | Binding ≤ 10μM |
Q4WNT5-1-O | 14-alpha Sterol Demethylase Cyp51A (cluster #1 Of 1), Other | Other | 3630 | 0.30 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q96W81_ASPFM | Q96W81 | 14-alpha Sterol Demethylase, Aspfm | 423 | 0.36 | Binding ≤ 1μM |
Q96W81_ASPFM | Q96W81 | 14-alpha Sterol Demethylase, Aspfm | 423 | 0.36 | Binding ≤ 10μM |
Q4WNT5_ASPFU | Q4WNT5 | 14-alpha Sterol Demethylase Cyp51A, Aspfu | 3630 | 0.30 | Binding ≤ 10μM |
CP2B6_HUMAN | P20813 | Cytochrome P450 2B6, Human | 1190 | 0.33 | ADME/T ≤ 10μM |
CP2CJ_HUMAN | P33261 | Cytochrome P450 2C19, Human | 5100 | 0.30 | ADME/T ≤ 10μM |
CP2C9_HUMAN | P11712 | Cytochrome P450 2C9, Human | 2800 | 0.31 | ADME/T ≤ 10μM |
Description | Species |
---|---|
CYP2E1 reactions | |
Fatty acids | |
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | |
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | |
Xenobiotics |